Prospective Registry of Acute Coronary Syndromes in Ferrara

NCT02438085 · tracked via the Priya Life Science Italy tracker

Sponsor

University Hospital of Ferrara

Phase

Observational

Started

2014-06

Last updated

2023-11-14

Condition(s) studied

Acute Coronary Syndromes

Investigational drug(s) / intervention(s)

prospective collection of data and follow-up

prospective collection of data and follow-up: prospective collection of data and follow-up of all patients admitted to hospital for ACS

Study summary

The ARYOSTO has been designed to describe the clinical epidemiology and the current management of acute coronary syndromes (ACS) in the area of Ferrara. Especially, the Authors will evaluate the medical and interventional management of ACS patients admitted to hospitals in the area of Ferrara and receiving coronary artery angiography and percutaneous coronary intervention (PCI) in the hub center of Ferrara (Azienda Ospedaliera Universitaria di Ferrara, Cona (FE), Italy)

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * age \>18 years * hospital admission for acute coronary syndromes * resident in the Ferrara area Exclusion Criteria: * none

Primary outcome measure(s)

1-year combined primary endpoint — 1 year
1-year occurence of cardiac death, myocardial infarction, cerebrovascular accident

Trial sites (1)

Facility	City	Region	Status
University Hospital of Ferrara	Cona	Ferrara	Recruiting

More University Hospital of Ferrara trials in Italy

Exercise Activity to Improve Mobility in Patients With CKD and PAD Recruiting

Diagnostic Accuracy of 18F-FDG PET/CT in Muscle-invasive Bladder Cancer Recruiting

TRanscatheter Aortic-Valve Implantation Without On-site Cardiac Surgery Recruiting

Effects of Physical Exercise and Cognitive Training on Quality of Life in Elderly Adults Recruiting

Scaffold in Emilia Romagna and in the MAGIC Network Recruiting

Other trials for the same condition

triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE Starting soon

Focused Orticumab Research for Treating Inflammation in Coronary Arteries Recruiting

EARLY: Educational Intervention to Improve Patient Awareness on Early LDL-C Lowering in Secondary Prevention Starting soon

Local And Systemic Macrophage Activation in Coronary and Peripheral Artery Disease Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02438085 on ClinicalTrials.gov ↗ ← All trials in Italy